Capricorn Fund Managers’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,758
Closed -$805K 75
2024
Q3
$805K Sell
6,758
-3,712
-35% -$495K 0.54% 40
2024
Q2
$1.49M Hold
10,470
1.05% 26
2024
Q1
$1.34M Buy
+10,470
New +$1.25M 0.81% 33
2023
Q4
Sell
-12,646
Closed -$1.15M 78
2023
Q3
$1.15M Buy
+12,646
New +$1.11M 0.4% 59
2023
Q2
Sell
-16,968
Closed -$1.35M 96
2023
Q1
$1.35M Buy
+16,968
New +$1.2M 0.41% 63
2022
Q4
Sell
-30,740
Closed -$1.53M 100
2022
Q3
$1.53M Buy
+30,740
New +$1.65M 0.48% 60
2022
Q2
Sell
-33,212
Closed -$1.84M 112
2022
Q1
$1.84M Buy
+33,212
New +$1.7M 0.45% 61

Other funds holding NVO

Capricorn Fund Managers's NVO Position: Q4 2024 in Review

Capricorn Fund Managers sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 6,758 shares — an estimated $805K sold.

Capricorn Fund Managers first reported a position in NVO in Q1 2022 and held it in 7 quarters. The position peaked at $1.84M in Q1 2022. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Capricorn Fund Managers reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Capricorn Fund Managers sold 6,758 Novo Nordisk shares in Q4 2024, an estimated $805K.
  • Capricorn Fund Managers first reported a position in Novo Nordisk in Q1 2022 and held it in 7 quarters.
  • Capricorn Fund Managers's Novo Nordisk position peaked at $1.84M in Q1 2022.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Capricorn Fund Managers's 13F filing for Q4 2024, filed 17 Jan 2025.